Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Mehta

Showing results (1-10 of 299) with videos related to

Pageof 30
Sort By:
Clinical Liver Disease|June 17, 2021
Liver Transplantation Criteria for Hepatocellular Carcinoma, Including Posttransplant ManagementNeil Mehta
Hepatology Communications|March 7, 2020
Hepatocellular Carcinoma-How to Determine Therapeutic OptionsNeil Mehta
Clinical Liver Disease|April 29, 2024
Updates in liver transplantation policy for patients with hepatocellular carcinoma (HCC)Neil Mehta
Clinics in Liver Disease|October 5, 2020
Downstaging to Liver Transplant: Success Involves Choosing the Right PatientKali Zhou, Neil Mehta
Expert Review of Gastroenterology & Hepatology|September 16, 2020
Recurrence of hepatocellular carcinoma following liver transplantationDaniel Hoffman, Neil Mehta
International Review of Psychiatry (Abingdon, England)|March 25, 2015
Online social support networksNeil Mehta, Ashish Atreja
American Journal of Public Health|October 12, 2012
Continued increases in the relative risk of death from smokingNeil Mehta, Samuel Preston
Medical Teacher|July 26, 2024
Embracing the illusion of explanatory depth: A strategic framework for using iterative prompting for integrating large language models in healthcare educationSeysha Mehta, Neil Mehta
Hepatology (Baltimore, Md.)|March 11, 2025
Reply: Downstaging of hepatocellular carcinoma before liver transplantationEdison Xu, Neil Mehta
Social Science & Medicine (1982)|March 8, 2016
Are major behavioral and sociodemographic risk factors for mortality additive or multiplicative in their effects?Neil Mehta, Samuel Preston
Pageof 30

Showing results (1-10 of 299) with videos related to

Sort By:
Pageof 30
Clinical Liver Disease|June 17, 2021
Liver Transplantation Criteria for Hepatocellular Carcinoma, Including Posttransplant ManagementNeil Mehta
Hepatology Communications|March 7, 2020
Hepatocellular Carcinoma-How to Determine Therapeutic OptionsNeil Mehta
Clinical Liver Disease|April 29, 2024
Updates in liver transplantation policy for patients with hepatocellular carcinoma (HCC)Neil Mehta
Clinics in Liver Disease|October 5, 2020
Downstaging to Liver Transplant: Success Involves Choosing the Right PatientKali Zhou, Neil Mehta
Expert Review of Gastroenterology & Hepatology|September 16, 2020
Recurrence of hepatocellular carcinoma following liver transplantationDaniel Hoffman, Neil Mehta
International Review of Psychiatry (Abingdon, England)|March 25, 2015
Online social support networksNeil Mehta, Ashish Atreja
American Journal of Public Health|October 12, 2012
Continued increases in the relative risk of death from smokingNeil Mehta, Samuel Preston
Medical Teacher|July 26, 2024
Embracing the illusion of explanatory depth: A strategic framework for using iterative prompting for integrating large language models in healthcare educationSeysha Mehta, Neil Mehta
Hepatology (Baltimore, Md.)|March 11, 2025
Reply: Downstaging of hepatocellular carcinoma before liver transplantationEdison Xu, Neil Mehta
Social Science & Medicine (1982)|March 8, 2016
Are major behavioral and sociodemographic risk factors for mortality additive or multiplicative in their effects?Neil Mehta, Samuel Preston
Pageof 30